These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35001402)

  • 1. Associations of human papillomavirus (HPV) genotypes and related risk factors in a cohort of women living with HIV in a Brazilian countryside city.
    Kury CMH; Guimaraes GR; Leandro CG; Fernandes LA; Silva PRT; M B Petraglia TC; Cruz OG; da Costa Carneiro R; Cavalcanti SMB
    J Med Virol; 2022 Jun; 94(6):2802-2810. PubMed ID: 35001402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus prevalence, genomic diversity and related risk factors in HIV-positive women from a countryside city in the state of Rio de Janeiro.
    Miguel Haddad Kury C; Santos KCDS; Carestiato FN; Rapozo G; Leandro CG; Fernandes LA; Silva PRT; Passos MRL; Cruz OG; Cavalcanti SMB
    Hum Vaccin Immunother; 2021 Mar; 17(3):838-844. PubMed ID: 32961070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination.
    Batmunkh T; Dalmau MT; Munkhsaikhan ME; Khorolsuren T; Namjil N; Surenjav U; Toh ZQ; Licciardi PV; Russell FM; Garland SM; Mulholland K; von Mollendorf C
    Vaccine; 2020 Jun; 38(27):4316-4324. PubMed ID: 32387009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
    Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
    Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine and Non-Vaccine HPV Types Presence in Adolescents with Vertically Acquired HIV Five Years Post Gardasil Quadrivalent Vaccination: The ZIMGARD Cohort.
    Murahwa AT; Mudzviti T; Mandishora RSD; Chatindo T; Chanetsa P; Pascoe M; Shamu T; Basera W; Luethy R; Williamson AL
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38275972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study.
    Egli-Gany D; Spaar Zographos A; Diebold J; Masserey Spicher V; Frey Tirri B; Heusser R; Dillner J; Petignat P; Sahli R; Low N;
    BMC Cancer; 2019 Jan; 19(1):111. PubMed ID: 30700274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of cervical, oral, and anal human papillomavirus infection in women living with HIV in Denmark - The SHADE cohort study.
    Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rönsholt FF; Johansen IS; Pedersen G; Gaardsting A; Nielsen LN; Bonde J; Lebech AM
    J Clin Virol; 2018 Aug; 105():64-71. PubMed ID: 29906660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark - the SHADE.
    Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rønsholt FF; Johansen IS; Pedersen G; Hashemi L; Nielsen LN; Nilas L; Obel N; Bonde J; Lebech AM
    BMC Cancer; 2016 Nov; 16(1):866. PubMed ID: 27821088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus prevalence and risk factors among Australian women 9-12 years after vaccine program introduction.
    Shilling H; Garland SM; Atchison S; Cornall AM; Brotherton JML; Bateson D; McNamee K; Kaldor JM; Hocking JS; Chen MY; Fairley CK; McNulty A; Bell C; Marshall L; Ooi C; Skinner SR; Murray G; Molano M; Tabrizi S; Machalek DA
    Vaccine; 2021 Aug; 39(34):4856-4863. PubMed ID: 34281743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk human papillomavirus genotypes distribution in a cohort of HIV-positive women living in Europe: epidemiological implication for vaccination against human papillomavirus.
    Konopnicki D; Manigart Y; Gilles C; Barlow P; De Marchin J; Feoli F; Delforge M; Clumeck N; De Wit S
    AIDS; 2016 Jan; 30(3):425-33. PubMed ID: 26765936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalent human papillomavirus infection increases the risk of HIV acquisition in African women: advancing the argument for human papillomavirus immunization.
    Liu G; Mugo NR; Brown ER; Mgodi NM; Chirenje ZM; Marrazzo JM; Winer RL; Mansoor L; Palanee-Phillips T; Siva SS; Naidoo L; Jeenarain N; Gaffoor Z; Nair GL; Selepe P; Nakabiito C; Mkhize B; Mirembe BG; Taljaard M; Panchia R; Baeten JM; Balkus JE; Hladik F; Celum CL; Barnabas RV
    AIDS; 2022 Feb; 36(2):257-265. PubMed ID: 34172672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study.
    Chow EPF; Tabrizi SN; Fairley CK; Wigan R; Machalek DA; Garland SM; Cornall AM; Atchison S; Hocking JS; Bradshaw CS; Balgovind P; Murray GL; Chen MY
    Lancet Infect Dis; 2021 Oct; 21(10):1448-1457. PubMed ID: 34043963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study.
    Chow EPF; Machalek DA; Tabrizi SN; Danielewski JA; Fehler G; Bradshaw CS; Garland SM; Chen MY; Fairley CK
    Lancet Infect Dis; 2017 Jan; 17(1):68-77. PubMed ID: 27282422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term human papillomavirus vaccination effectiveness and immunity in Rwandan women living with and without HIV: a study protocol.
    Murenzi G; Shumbusho F; Hansen N; Munyaneza A; Gage JC; Muhoza B; Kanyabwisha F; Pierz A; Tuyisenge P; Anastos K; Castle PE
    BMJ Open; 2022 Aug; 12(8):e061650. PubMed ID: 36008069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV genotyping in biopsies of HSIL and invasive cervical cancers in women living with HIV: A cohort- and a nested -case control study.
    Gilles C; Rozenberg S; Buxant F; Manigart Y; de Wind R; Houte KV; Vandenbroeck D; Delforge M; Konopnicki D
    Vaccine; 2022 Nov; 40(50):7230-7237. PubMed ID: 36328880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus.
    Palefsky JM; Lensing SY; Belzer M; Lee J; Gaur AH; Mayer K; Futterman D; Stier EA; Paul ME; Chiao EY; Reirden D; Goldstone SE; Tirado M; Cachay ER; Barroso LF; Da Costa M; Darragh TM; Rudy BJ; Wilson CM; Kahn JA
    Clin Infect Dis; 2021 Oct; 73(8):1388-1396. PubMed ID: 33991185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program.
    Garland SM; Cornall AM; Brotherton JML; Wark JD; Malloy MJ; Tabrizi SN;
    Vaccine; 2018 May; 36(23):3221-3230. PubMed ID: 29724506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief Report: Persistence of Non-Vaccine Oncogenic HPV Genotypes in Quadrivalent HPV-Vaccinated Women Living With HIV.
    McClymont E; Coutlée F; Lee M; Albert A; Raboud J; Walmsley S; Lipsky N; Loutfy M; Trottier S; Smaill F; Klein MB; Yudin MH; Harris M; Wobeser W; Bitnun A; Samson L; Money D;
    J Acquir Immune Defic Syndr; 2020 Mar; 83(3):230-234. PubMed ID: 31917750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark - the SHADE.
    Thorsteinsson K; Ladelund S; Storgaard M; Katzenstein TL; Johansen IS; Pedersen G; Rönsholt FF; Nielsen LN; Nilas L; Franzmann M; Obel N; Lebech AM; Bonde J
    BMC Infect Dis; 2019 Aug; 19(1):740. PubMed ID: 31438877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk factors associated with high-risk human papillomavirus infection among women living with HIV (WLWH) at a tertiary health facility in Accra, Ghana.
    Agyare Gyane F; Modey E; Maya E; Bonney EY; Abaidoo-Myles A; Paintsil E; Torpey K
    PLoS One; 2024; 19(5):e0303535. PubMed ID: 38814956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.